IHS Chemical Week

Regions :: Western Europe :: Netherlands

Akzo Nobel Restates Plan to List Pharma Business

1:38 PM MDT | January 31, 2007 | Chemical Week Editorial Staff

Akzo Nobel has restated its intention to divest a 20%-30% stake in its Organon BioSciences (OBS) pharmaceuticals business early this year through an initial public offering, quashing speculation that Akzo will sell OBS to a consortium of private equity companies. “Over the last few weeks, Akzo has received preliminary expressions of interest from a number of parties regarding an acquisition of OBS,” the company says. “Akzo has carefully reviewed these proposals and reconfirms that it remains committed to a separate listing for OBS.”...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa